Financial Gravity Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5
| Closed | -$312 | – | 1667 |
|
|
2024
Q1 | $312 | Sell |
5
-151
| -97% | -$9.42K | ﹤0.01% | 1521 |
|
|
2023
Q4 | $6.07K | Hold |
156
| – | – | ﹤0.01% | 853 |
|
|
2023
Q3 | $6.07K | Buy |
156
+100
| +179% | +$3.89K | ﹤0.01% | 624 |
|
|
2023
Q2 | $387 | Buy |
+56
| New | +$387 | ﹤0.01% | 1041 |
|
|
2023
Q1 | – | Sell |
-41
| Closed | -$394 | – | 1251 |
|
|
2022
Q4 | $394 | Sell |
41
-1,064
| -96% | -$10.2K | ﹤0.01% | 835 |
|
|
2022
Q3 | $3.51K | Buy |
+1,105
| New | +$3.51K | 0.12% | 185 |
|
|
2022
Q2 | – | Sell |
-63
| Closed | -$4 | – | 760 |
|
|
2022
Q1 | $4 | Sell |
63
-13
| -17% | -$1 | ﹤0.01% | 815 |
|
|
2021
Q4 | $6 | Buy |
+76
| New | +$6 | ﹤0.01% | 886 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 322 |
|